cognitive cybersecurity intelligence

News and Analysis

Search

Evotec completes acquisition of Rigenerand

An Italian-based cell therapy business has just been bought by Evotec SE, a German therapeutics company.

Evotec just announced the strategic transaction to buy Rigenerand Srl, with the deal, signed in May 2022, now completed.

Based out of Medolla, Italy, the cell technology…

Source: www.labiotech.euRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts